Zolbetuximab
Oct 31, 2024•20 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The first Cldn 18.2 targeting monoclonal antibody has been improved. Let's talk about it!
For the best experience, listen in Metacast app for iOS or Android